John Maslowski is Chief Scientific Advisor and Chairman of the Scientific Advisory Board of Castle Creek Biosciences, Inc., previously serving as Chief Operating Officer. Formerly, he served as Chief Executive Officer of Castle Creek Biosciences and was President and Chief Executive Officer of Fibrocell Science, Inc. Mr. Maslowski has extensive experience in the field of cell and gene therapy, including advancing cell therapy and vaccine candidates through U.S. FDA approval and commercialization.
Mr. Maslowski currently serves on the Board of Directors of the Alliance for Regenerative Medicine, an international advocacy organization dedicated to regenerative medicines and advanced therapies, and the Advisory Board of Life Science Cares Philadelphia, a charitable organization. Previously, he served as Chairman of the Board of Directors of Falcon Therapeutics, a private Durham, N.C. company focused on the development of cell therapy products for oncology.
He earned a B.S. in biology from Ursinus College and an M.S. in microbiology from Villanova University.
